![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ARHGEF26-AS1 |
Gene summary for ARHGEF26-AS1 |
![]() |
Gene information | Species | Human | Gene symbol | ARHGEF26-AS1 | Gene ID | 100507524 |
Gene name | ARHGEF26 antisense RNA 1 | |
Gene Alias | ARHGEF26-AS1 | |
Cytomap | 3q25.2 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
100507524 | ARHGEF26-AS1 | HCC1 | Human | Liver | HCC | 7.19e-14 | 1.31e+00 | 0.5336 |
100507524 | ARHGEF26-AS1 | HCC2 | Human | Liver | HCC | 6.10e-25 | 2.39e+00 | 0.5341 |
100507524 | ARHGEF26-AS1 | HCC5 | Human | Liver | HCC | 7.01e-20 | 2.00e+00 | 0.4932 |
100507524 | ARHGEF26-AS1 | RNA-P17T-P17T-2 | Human | Lung | IAC | 7.81e-07 | 7.24e-01 | 0.3371 |
100507524 | ARHGEF26-AS1 | RNA-P17T-P17T-4 | Human | Lung | IAC | 6.81e-04 | 6.27e-01 | 0.343 |
100507524 | ARHGEF26-AS1 | RNA-P17T-P17T-6 | Human | Lung | IAC | 4.61e-04 | 5.67e-01 | 0.3385 |
100507524 | ARHGEF26-AS1 | RNA-P17T-P17T-8 | Human | Lung | IAC | 2.06e-16 | 1.00e+00 | 0.3329 |
100507524 | ARHGEF26-AS1 | RNA-P25T1-P25T1-1 | Human | Lung | AIS | 1.13e-04 | 4.20e-01 | -0.2116 |
100507524 | ARHGEF26-AS1 | RNA-P25T1-P25T1-3 | Human | Lung | AIS | 2.66e-03 | 4.52e-01 | -0.2107 |
100507524 | ARHGEF26-AS1 | RNA-P25T1-P25T1-4 | Human | Lung | AIS | 1.90e-03 | 3.63e-01 | -0.2119 |
100507524 | ARHGEF26-AS1 | RNA-P6T2-P6T2-1 | Human | Lung | IAC | 6.24e-13 | 4.71e-01 | -0.0166 |
100507524 | ARHGEF26-AS1 | RNA-P6T2-P6T2-2 | Human | Lung | IAC | 1.61e-12 | 4.58e-01 | -0.0132 |
100507524 | ARHGEF26-AS1 | RNA-P6T2-P6T2-3 | Human | Lung | IAC | 3.17e-20 | 5.88e-01 | -0.013 |
100507524 | ARHGEF26-AS1 | RNA-P6T2-P6T2-4 | Human | Lung | IAC | 3.39e-07 | 3.64e-01 | -0.0121 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Thyroid | PTC | ![]() |
Thyroid | goiters | ![]() |
Thyroid | ATC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |